about
Endoglin regulates mural cell adhesion in the circulatory systemThrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic propertiesImpact of aspirin and clopidogrel interruption on platelet function in patients undergoing major vascular surgeryBone marrow cell therapy in cardiovascular disease drives us slowly to a better identification of the active cell componentBone marrow-derived mononuclear cell therapy induces distal angiogenesis after local injection in critical leg ischemia.Circulating endothelial cells in refractory pulmonary hypertension in children: markers of treatment efficacy and clinical worsening.Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolismThrombin bound to a fibrin clot confers angiogenic and haemostatic properties on endothelial progenitor cells.Increased VEGFR2 expression during human late endothelial progenitor cells expansion enhances in vitro angiogenesis with up-regulation of integrin alpha(6)E-selectin mediates stem cell adhesion and formation of blood vessels in a murine model of infantile hemangiomaEndothelial progenitor cells: characterization, in vitro expansion, and prospects for autologous cell therapy.α6-Integrin is required for the adhesion and vasculogenic potential of hemangioma stem cellsProtein S Heerlen mutation heterozygosity is associated with venous thrombosis risk.Postischemic revascularization: from cellular and molecular mechanisms to clinical applications.Circulating endothelial cells: a new biomarker of endothelial dysfunction in hematological diseases.The Wnt antagonist Dickkopf-1 increases endothelial progenitor cell angiogenic potential.Human very Small Embryonic-like Cells Support Vascular Maturation and Therapeutic Revascularization Induced by Endothelial Progenitor Cells.Very Small Embryonic-like Stem Cells Are Mobilized in Human Peripheral Blood during Hypoxemic COPD Exacerbations and Pulmonary Hypertension.PDGFB, a new candidate plasma biomarker for venous thromboembolism: results from the VEREMA affinity proteomics study.Reduced proliferation of endothelial colony-forming cells in unprovoked venous thromboembolic disease as a consequence of endothelial dysfunction.Treprostinil increases the number and angiogenic potential of endothelial progenitor cells in children with pulmonary hypertension.Interleukin 8 is differently expressed and modulated by PAR-1 activation in early and late endothelial progenitor cells.Platelet microparticle levels: a biomarker of thromboangiitis obliterans (Buerger's disease) exacerbation.Maize- or potato-derived hydroxyethyl starches: is there any thromboelastometric difference?Forearm ischemia decreases endothelial colony-forming cell angiogenic potential.Interpretation of idarucizumab clinical trial data based on spontaneous reports of dabigatran adverse effects in the French pharmacovigilance database.Whole-genome analysis reveals unexpected dynamics of mutant subclone development in a patient with JAK2-V617F-positive chronic myeloid leukemia.A bioprosthetic total artificial heart for end-stage heart failure: Results from a pilot study.The Carmat Bioprosthetic Total Artificial Heart Is Associated With Early Hemostatic Recovery and no Acquired von Willebrand Syndrome in Calves.Egfl7 Represses the Vasculogenic Potential of Human Endothelial Progenitor Cells.Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia.Human endoglin as a potential new partner involved in platelet-endothelium interactions.The heart regulates the endocrine response to heart failure: cardiac contribution to circulating neprilysin.Endothelial Microparticles are Associated to Pathogenesis of Idiopathic Pulmonary Fibrosis.First clinical use of a bioprosthetic total artificial heart: report of two cases.Bone morphogenetic proteins 2 and 4 are selectively expressed by late outgrowth endothelial progenitor cells and promote neoangiogenesis.The angiopoietin pathway is modulated by PAR-1 activation on human endothelial progenitor cells.Bone Marrow Very Small Embryonic-Like Stem Cells: New Generation of Autologous Cell Therapy Soon Ready for Prime Time?Targeting VEGFR1 on endothelial progenitors modulates their differentiation potential.Thrombin receptor PAR-1 activation on endothelial progenitor cells enhances chemotaxis-associated genes expression and leukocyte recruitment by a COX-2-dependent mechanism.
P50
Q27326704-F8BDC153-BFA3-41A9-8C52-512167944F11Q28300388-157D4C98-1375-403E-8F46-9F6A4958532AQ28542407-833F32F1-883C-4447-834F-02836544B3EDQ33746101-F3100C7A-F044-4831-A406-BA406932D97EQ34011783-A28F4EBF-696D-4290-86A4-23B7F05EDDAEQ34769618-B9217579-4962-4119-9F35-6F87004CA396Q35266365-98A2B63E-6B5A-4FF8-B998-CFD818CB3D44Q35458444-97C4324C-889C-4525-B4F9-3EB9FFA8CF08Q35459633-29C9A016-9292-4834-AC0F-075633E3779CQ36433043-D2B0A036-5206-4F0E-AC5E-6250447A1E08Q36763667-A84460B2-5AF3-4C8E-8BB8-BC6C14F9325CQ37620426-E5CCBBFA-2967-499B-8029-C860E371282DQ37736739-B5681C6D-F6FA-4D37-9092-3B0AE8C8CFB6Q38153677-D7714758-E475-40F4-BB15-7A742FD12DA5Q38834364-608A02D1-C16F-4DBD-80EB-67FA56599F75Q39654990-F13C6122-E24D-42C5-9D11-A95E3D5E1C46Q40290558-54AB783C-BABB-4EA0-89F9-BB9DB1D2C4E4Q40297970-96E1E556-E478-4103-AB09-F0E5E30CB4C9Q40541385-FCF29957-8080-4774-8A10-BFF03ED840B2Q41073138-C458D60A-C23B-45A4-A45D-B0710B4E1462Q41895695-67D1CC3E-158C-4E59-87F5-514B0C985F94Q42439415-15A1EBB2-FB3C-4ED6-B54F-3A90F3018B6BQ42872519-42AF114E-D38C-4F7C-BB9C-D893F7347015Q42907613-C319C71B-490D-4797-8814-8C61A897A997Q43744046-B0F1C6AA-F364-4A9A-9C51-258ED411AD16Q46396825-05CC380E-9EB6-4D10-88AA-A0858C1C9E66Q47208518-3C3A6DD2-1E7E-44E6-8C1D-0BD0C89D7C6DQ47244239-FBC4122E-753A-4049-A50C-197655BDD303Q47281598-AC3EF2AB-9E20-4FA0-B2B2-33F335874239Q47694726-609755DA-AF84-451E-A209-748AA0C325E8Q47968783-CF06DDF1-438C-4428-856B-2B62537F434DQ48109054-4CD4EE09-0CBB-413F-AE74-3E6C62ED30BBQ49825721-02090D76-9C75-4A00-A73F-461F3C3B99CDQ50171347-BBD74DF1-D9DC-4D91-8510-504387C6FD59Q50576348-7C25709C-82BC-49FA-9EFE-D91690FCACD3Q50775497-D94944FD-D4AD-4103-BF18-ABDBC06B1ED0Q50933010-E88DAF64-0E91-4B5B-BAD4-DB75A83F58BDQ50946128-A0CECB77-D1F2-4B34-9798-EDE54196EC12Q52646840-23B21981-A9F2-478C-833A-59EA021F2747Q53221287-D602C759-F22E-4134-A5C3-9708260DAC9F
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
David M. Smadja
@ast
David M. Smadja
@en
David M. Smadja
@es
David M. Smadja
@sl
type
label
David M. Smadja
@ast
David M. Smadja
@en
David M. Smadja
@es
David M. Smadja
@sl
altLabel
David M. Smadja
@en
David Smadja
@en
prefLabel
David M. Smadja
@ast
David M. Smadja
@en
David M. Smadja
@es
David M. Smadja
@sl
P214
P244
P1053
M-3872-2017
P106
P1153
14066761600
P2002
P21
P214
P244
n2014181108
P31
P3829
P496
0000-0001-7731-9202
P734
P735
P7859
lccn-n2014181108